Introduction
Ovarian cancer accounts for about 4% of worldwide cancer incidence and mortality among women. As the seventh most common cancer and the eighth leading cause of cancer-related death in 2012 with 238,700 cases and 151,900 deaths, 1 ovarian cancer has nonspecific symptoms, causing more than 60% of cases to be diagnosed at late stage, with a 5-year survival rate of 30%-40% in most countries. 2 Ovarian clear cell carcinoma (OCCC) is considered a rather intriguing subtype among ovarian cancers due to its distinct histopathologic subtype, worse prognosis, and resistance to conventional platinum-based chemotherapy. Studies showed that OCCC has higher prevalence rate in East Asia (15%-25%) than in North America and Europe (1%-12%) due to race difference. 3 OCCC occupies less than 5% of all ovarian cancers. 4 An increased body mass index >30 and endometriosis are associated with this histological subtype on the basis of several studies with an OR of 2.2-2.3.
High levels of vascular endothelial factor (vascular endothelial growth factor) expression were revealed in OCCC, correlating with shorter survival. Upregulation of IL-6/STAT-3/hypoxia-inducible factor signaling can also be found in OCCC, which is fundamental in hypoxia-induced angiogenesis. 6 HER2 is overexpressed in 14% of OCCCs, 7 suggesting a further potential therapeutic agent. Regarding somatic mutations of OCCC, mutations of PIK3CA (32%-33%), ARID1A (46%), KRAS, and BRAF are frequently presented. [8] [9] [10] Though rarely seen, reliable genetic diagnosis and target therapy for the precise treatment of OCCC patients are needed as its poor prognosis and resistance in chemotherapy. Both clinical approaches and genomic approaches are necessary in this quest. 11 However, low incidence of OCCC and small number of samples bring obstacles in clinical trial, experimental research, and genomic analysis.
In this study, bioinformatical methods were applied to detect the differentially expressed genes (DEGs) between OCCC and normal human ovary tissue on gene expression profiling data downloaded from the Gene Expression Omnibus (GEO) database. Gene Ontology (GO) function and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis and protein-protein interaction (PPI) network analysis were performed to detect novel indicators of OCCC patients and endeavor to provide potential therapeutic targets for this unique disease.
Materials and methods

Microarray data download and processing
The gene expression profiles of GSE6008, GSE29450, GSE18520, GSE54388, and GSE63885 were downloaded from GEO database (https://www.ncbi.nlm.nih.gov/geo/). GSE6008 was based on GPL96 [HG-U133A] Affymetrix Human Genome U133A array platform. GSE29450, GSE18520, GSE54388, and GSE63885 were based on GPL570 [HG-U133_Plus_2] Affymetrix Human Genome U133 plus 2.0 array platform. GSE63885 contains no normal ovary tissue samples, while GSE18520 and GSE54388 contain no OCCC tissue samples; these three datasets were merged into one named "Dataset C" before further analysis. The original CDF files of the platform and CEL files of the arrays were downloaded from GEO website and Gene Chip Robust Multichip Average was used for normalization, which can adjust the background intensity and normalize the probe intensity of Affymetrix data in the merging process. The data after normalization are exported as Dataset C and analyzed. All datasets were renormalized at the probe level before analysis. All of the data were freely available online.
Tumor and normal ovary samples
Four tumor samples came from four OCCC patients treated at the Peking Union Medical College Hospital, Beijing, China. All patients had been treated with initial cytoreductive surgery followed by platinum-based chemotherapy. Four normal ovary tissue samples came from four benign disease patients surgically treated at the Peking Union Medical College Hospital. All samples were stored in liquid nitrogen tank after dissection. This study was approved by the ethics committee of Peking Union Medical College Hospital. All patients provided written informed consent before the study. This was conducted in accordance with the Declaration of Helsinki. All data were de-identified.
Data processing of DEGs
The GEO2R online analysis tool (https://www.ncbi.nlm. nih.gov/geo/geo2r/) was used to detect the DEGs between OCCC and normal samples, and the adjusted P-value and |log2FC| were calculated. Genes that met the cutoff criteria, adjusted P<0. 05 
PPI network and module analysis
To evaluate the interactive relationships among DEGs, we mapped the DEGs to the Search Tool for the Retrieval of Interacting Genes (STRING) database (http://string-db.org/) with a combined score >0.4. PPI networks were constructed using the Cytoscape software. Nodes with higher degree of connectivity tend to be more essential in the functional network. The top six genes with degree of connectivity >10 were identified as hub genes. Table S1 . The PCR amplification was performed for 40 cycles of 95ºC for 5 seconds and 60ºC for 30 seconds, and melting curve reaction was performed at the end. All data analyses were operated using the 7500 Fast RealTime PCR Systems (Applied Biosystems). The ΔΔCt method was used to assess the relative expression of different genes.
Western blotting analysis
Tissues were collected and lysed in RIPA (Thermo Fisher Scientific, Waltham, MA, USA) buffer supplemented with phenyl-methane-sulfonyl fluoride (Boster Biology, Pleasanton, CA, USA). The concentration of protein samples was detected using a BCA Protein Assay Kit (Beyotime Institute of Biotechnology). Equal amounts of lysates were separated by 10% SDS-PAGE gels and transferred to polyvinylidene difluoride membranes. Membranes were blocked for 1 hour in BSA blocking buffer (Solarbio Life Sciences, Beijing, China) and probed with primary antibodies (at a dilution of 1:1,000) at 4ºC for 12 hours (rabbit monoclonal to WT1, research resource identifier (RRID): ab89901; rabbit polyclonal to SPP1, RRID: ab8448; rabbit polyclonal to DCN, RRID: ab175404; rabbit polyclonal to EPCAM, RRID: ab71916; rabbit monoclonal to ALDH1A1, RRID: ab52492; rabbit polyclonal to Gata6, RRID: ab22600; and rabbit polyclonal to beta actin, RRID: ab8227). All were purchased from Abcam Corporation. Then they were incubated with the specific horse radish peroxidase (HRP)-conjugated secondary antibody (goat antirabbit IgG HRP [ab6721] from Abcam) for 2 hours before developing with the ECL kit (Merck Millipore, Kenilworth, NJ, USA). Data analysis was performed using ImageJ software to evaluate the expression levels of proteins. Statistical analysis was performed using SPSS 17.0 software (IBM Corp., Armonk, NY, USA) and with GraphPad Prism, version 5 (GraphPad Software). Statistically significant differences (P<0.01) were determined by Student's t-test or ANOVA in the RT-PCR test and Western blotting analysis, presented as mean ± SD.
Results
Identification of DEGs
Five microarray datasets (GSE6008, GSE29450, GSE18520, GSE54388, and GSE63885) and the number of tumor and normal ovary tissue samples are shown in Table 1 . GSE63885 contains no normal ovary tissue samples. GSE18520 and GSE54388 contain no OCCC tissue samples. To accomplish the comparison between normal ovary tissue and tumor, these three datasets were merged into one named "Dataset C". The GEO2R online analysis tool was used to identify DEGs separately with the cutoff criteria, adjusted P<0.05 and |log2FC|>2.0 (Table 1) , to compare OCCC samples with normal ovary samples. DEGs expression heat maps and volcano plots are shown in Figures 1  and 2 . Venn analysis was performed to get the intersection of the DEG profiles ( Figure 3) . Finally, 43 DEGs were significantly differentially expressed among all three groups, of which 30 were significantly upregulated genes and 13 were downregulated genes.
GO function and KEGG pathway enrichment analysis of DEGs g: Profiler were used to analyze GO function and KEGG pathway enrichment for DEGs ( Table 2 ). The enriched GO terms were divided into CC, BP, and MF ontologies. DEGs were mainly enriched in BPs, including tissue development, epithelium development, epithelial cell differentiation, tube development, organ development, and morphogenesis. MF analysis showed that the DEGs were significantly enriched in protein binding. For cell component, the DEGs were enriched in extracellular region, organelle, 
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Z score gene expression GSM729046  GSM1314224  GSM1314227  GSM1559398  GSM1559391  GSM1559395  GSM1559392  GSM1559393  GSM1559399  GSM1559396  GSM1559397  GSM1559394  GSM1314226  GSM1314225  GSM1314223  GSM1314222  GSM462645  GSM462646  GSM462644  GSM462643  GSM462648  GSM462651  GSM462652  GSM462650  GSM462647  GSM462649  GSM729053  GSM729049  GSM729051  GSM729050  GSM729052  GSM729047  GSM729048  GSM729044  GSM729045  GSM729043  GSM729041  GSM729034  GSM729042  GSM729040  GSM729035  GSM729039  GSM729037  GSM729036  GSM729038   MSH6  NR4A2  ADAMTS5  SPRR2B  RGS2  STON1  OGN  FAM198B  ZFPM2  PDGFD  WT1  OLFML3  KLF4  KLF2  CHST7  LRRC17  C4BPB  PEG10  KLHDC8A  GATA6  CDKN1C  KIT  MFAP4  PELI2  ANGBMP4  TCF21  SNCF21  SNCAIP  RBP1  ALDH1A1  ABCA8  PMP22  STAR  PRKAR2B  FOSB  ADIRF  MAOB  GAS1  GPRASP1  CFH  RNASE4  RARRES2  ITM2A  CLEC2B  RCBO3  CYBRD1  DCN  PINLYP  S100P  MSLN  BIK  Ml  aogb2a1  GR2  NMU  COMP  LEFTY1  WFDC2  FOLR1  PROM1  EFNA1  CXCL14  EEF1A2  WNT17A  VCAN  FXYD2  MFHAS1  MUC1  SLC34A2  KLK8  LBP  OLDN3  C1orf106  PRSS8  EPCAM  SLPI  DEFB1  OLDN4  HGD  CP  SPINT1  OD24  ESRP1  IGSF3  SFN  LAMA5  AOC1  LCN2  TMPRSS4  APOL1  VTCN1  PDZK1IP1  KCNJ16  TSPAN1   TMEM255A  REEP1  LGALS2  AADACL2  MSLN  TCEAL7  RARRES1  TGM1  BNC1  AQP9  MARCO  ADH1B  HSD17B6  LINC01279  GPR133  PKHD1L1  MUM1L1  HAND2-AS1  CALB2  C21orf62  CRISP3  UPK3B  MNDA  SEL1L2  HBD  OGN  ADIRF  ITLN1  SERTM1  C2orf40  RAB38  CHRDL1  TCEAL2  SHISA3  ADH1C  HBB  ZFPM2  RNASE4  BCHE  PRG4  AOX1  RSPO1  HAS1  OLEC4M  RGS4  PPP1R14A  LOC100132735  LEFTY1  DEEB1  SLC3A1  UGT2A3  MOGAT1  RXFP1  RASD1  LOC100422737  CP  TMPRSS4  AOC1  DPPA2  SFTA2  SDC1  LOC100505776  SOGB2A1  C8orf4  PROM1  UGT2B28  C2CD4A  CDH16  KCNJ16  SLC10A4  RELN  APELA  RFX6  LIN28A  ELTD1  PDCL2  ZIC2  LOC101929144  FLJ41455  GLDC  MMP1  MLA  SOX17  PRAME  CLDN3  EPCAM  FOXM1  CD24  12orf56  MNX1   TMEM100  UPK3B\HP  NPY1R  ANXA8  SPPOCK1  CLEC4M  EMX2  LONRF2  NAP1L3  PODH9  GADL1  AADACL2  KCNT2  PRG4  MICU3  PROCR  CCDC80  BCHE  GPR133  CGN  MEOX2  ADH1B  SULF1  NELL2  MNDA  CHRDL1  ANXA8L1  DPP10  REEP1  RSPO1  SHISA3  BNC2  CALB2  ITLN1  SERTM1  RERG  MEDAG  TRPC1  TCEAL2  TMEM255A  MEIS2  SCG5  MUM1L1  PLSCR4  ZPFM2  EFEMP1  MGARP  RNF128  EEF1A2  MMP7  DEFB1  CA2  LEFTY1  SFTA2  AOC1  PSAT1  S100P  HGD  MAL  COMP  EPCAM  CHMP4C  DCDC2  CITED2  CP  SOX17  FOXQ1  SCGBA  CD24  OLDN3  PRAME  PROM1  RXFP1  C12orf75  PNP  SLC3A1  C2OD41  GLRX  CFL1  PFN1  HSP18A  OLDN7  TMED2  PKM  P4HB  CD46  COL4A2  COL4A1  C1orf106  VTON1  NPTX2  PRSS8 ZIC2 FOLR1 Figure 1 Heat maps of the differentially expressed genes of (A) GSE6008, (B) GSE29450, and (C) Dataset C. Note: Red: upregulation; green: downregulation. Figure 2 Volcano plots of the differentially expressed genes of (A) GSE6008, (B) GSE29450, and (C) Dataset C. Note: Red: upregulation; green: downregulation.
A B C
and space. The results of KEGG pathway analysis showed that DEGs were mainly enriched in extracellular matrix (ECM)-receptor interaction pathway and TGF-beta signaling pathway.
PPI network analysis
To explore the potential relationship between the aberrantly expressed genes, we performed a PPI network analysis with the online software STRING (score >0.4). Results were visualized by Cytoscape, as presented in Figure 4 . The top six genes evaluated by connectivity degree in the PPI network were identified (Table 3 ). Two of these hub genes (SPP1, EPCAM) are upregulated in OCCC.
RT-PCR and western blotting analysis
We used four OCCC tumor tissue samples and four normal ovary tissue samples to evaluate the expression level of the six hub genes by RT-PCR and Western blotting analysis. As is shown in Figure 5A , B, mRNA and protein levels of both SPP1 and EPCAM were significantly upregulated in 
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Identification of potential key genes associated with OCCC carcinoma than normal tissues (P<0.01). However, the other four downregulated genes showed no significant difference between two groups.
Discussion
OCCC is a distinct histopathologic subtype of ovarian cancer.
Other than the common characteristics of nonspecific symptoms and low survival rate of ovarian cancer, OCCC shows worse prognosis and resistance to conventional platinumbased chemotherapy, resulting in substantial obstacles for cancer treatment. Although OCCC only occupies less than 5% of all ovarian cancers, efforts have been devoted into the clinical and experimental research on OCCC, in which reliable genetic diagnosis and target therapy remain essential but unclear. Both clinical and genomic approaches are necessary in this quest. However, low incidence of OCCC and small number of samples bring obstacles in clinical trial, experimental research, and genomic analysis. In the present study, five gene expression datasets were retrieved from GEO, including microarray information of 27 OCCC samples and 30 normal ovary samples. Gene expression and protein-protein expression analyses based on public databases were performed to identify potential key genes correlated with OCCC and screen out DEGs. We identified 30 upregulated DEGs and 13 downregulated DEGs, which were mainly enriched in BPs in GO analysis, including tissue development, epithelium development, epithelial cell differentiation, tube development, organ development, and morphogenesis. MF analysis showed that the DEGs were significantly enriched in protein binding. For cell component, the DEGs were enriched in extracellular region and organelle.
The results of KEGG pathway analysis showed that DEGs were mainly enriched in ECM-receptor interaction pathway and TGF-beta signaling pathway.
By PPI network analysis, six hub genes were identified, including WT1, SPP1, DCN, EPCAM, ALDH1A1, and GATA6, two of which (SPP1, EPCAM) are upregulated in OCCC. Four OCCC tumor tissue samples and four normal ovary tissue samples were used to evaluate the expression level of the six hub genes by RT-PCR and Western blotting analysis. mRNA and protein levels of both SPP1 and EPCAM were significantly upregulated in tumor than normal tissues while no significant expression difference between groups was found for the other four downregulated genes .
EPCAM is a epithelial cell adhesion molecule (CAM) that does not belong to any of the four CAMs families (cadherins, selectins, integrins, and immunoglobulin-like CAMs) and discovered as one of the first cancer markers. 12 It is a cell surface glycoprotein of ~40 kDa and is highly expressed in epithelial cancers. EPCAM may play key roles in the progression of ovarian cancer through promoting migration, proliferation, inhibiting cell apoptosis and adhesion, and disturbing cell cycle. It may be used as specific therapeutic targets in the treatment of ovarian cancer. 13 EPCAM is suggested to be the DEGs between ovarian carcinomas and normal ovarian epithelium, indicating its involvement in the pathogenesis of ovarian cancer.
14, 15 Battista et al found that overexpression of EPCAM retains its significance independent of established prognostic factors for longer progression-free survival (PFS) (HR, 0.408; 95% CI, 0.197-0.846; P=0.003) but not for PFS (HR, 0.666; 95% CI, 0.366-1.212; P=0.183). 16 Another study indicated a significant association of EPCAM overexpres- 
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Xu and shen sion with a more favorable survival in epithelial ovarian cancer patients. Serous cancers showed a significant EPCAM overexpression compared with mucinous types in ovarian carcinoma. 17 In addition, serum EPCAM level was found to be a diagnostic marker in epithelial ovarian cancer patients. 18 Secreted phosphoprotein 1 (SPP1) is a secreted arginine glycine aspartic acid containing phosphorylated glycoprotein, with a molecular weight of about 325 kDa. 19 The human SPP1 gene is located on chromosome 4 with seven exons and six introns. 20 The expression of SPP1 is strongly related to tumor metastasis in gastric cancer and esophageal adenocarcinoma. [21] [22] [23] Previous studies showed that SPP1 is highly expressed in many kinds of tumors, such as colon cancer, prostate cancer, lung cancer, and breast cancer. [24] [25] [26] Modulation of vascular endothelial growth factor expression and regulation of extracellular matrix protein are the classic pathways in which SPP1 facilitates cancer progression. 27, 28 Recent study of SPP1 in epithelial ovarian cancer reveals that the expression of SPP1 was higher in cancer tissues than in normal ovarian tissues. And it could be a useful biomarker 
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Identification of potential key genes associated with OCCC in diagnosis of ovarian cancer with the diagnostic sensitivity and specificity of 0.66 (95% CI, 0.51-0.78) and 0.88 (95% CI, 0.78-0.93), respectively. 29 Silencing SPP1 decreased the cell proliferation, migration, and invasion in vitro and prevented ovarian cancer growth in mice, during which the integrin β1/FAK/AKT pathway was simultaneously inhibited. 30 However, the expression and function of SPP1 in OCCC remain unclear. Therefore, SPP1 may be a prognostic factor and potential therapeutic target for OCCC. However, larger multicenter analysis is still needed to confirm these results. In our study, WT1, DCN, ALDH1A1, and GATA6 were downregulated in cancer compared to normal tissues by bioinformatic analysis. However, the RT-PCR and Western blotting analysis suggest otherwise. The role of these genes in OCCC is not clear. Experimental research of the biological functions of these genes in cancer cell lines is needed in the following study and can be illustrated in the future. Studies of large sample are required to evaluate the value of SPP1, EPCAM, and other genes in the prognostic evaluation and precise treatment of OCCC.
Conclusion
Our research identified six hub genes as potential key genes of OCCC by bioinformatic analysis. SPP1 and EPCAM are overexpressed in OCCC compared with normal ovary tissue. Experimental research is needed to reveal the biological functions of these genes in cancer cell lines. Clinical study of large sample is required to evaluate the value of SPP1 and EPCAM in the precision treatment and prognostic influence on OCCC.
